After about 15 years of research and development, testing and clinical trials, of fine-tuning and evolving from a laptop-based technology to a pocket-sized mobile device, Damiano’s dream for his son, and everyone with type 1 diabetes, is on the cusp of becoming a reality.

Ed Damiano and his research team have received funding from a variety of sources. Of the $18 million raised through Boston University to fund his program over the past decade, half has come from the National Institutes of Health.